May & Baker Nigeria plc Stock

Equities

MAYBAKER

NGMAYBAKER01

Pharmaceuticals

End-of-day quote Nigerian S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
6 NGN -.--% Intraday chart for May & Baker Nigeria plc -.--% +14.29%

Financials

Sales 2022 14.33B 10.32M 14.18M Sales 2023 19.7B 14.18M 19.5M Capitalization 9.06B 6.52M 8.97M
Net income 2022 1.49B 1.07M 1.48M Net income 2023 1.08B 780K 1.07M EV / Sales 2022 0.7 x
Net Debt 2022 2.65B 1.91M 2.63M Net Debt 2023 3.33B 2.4M 3.29M EV / Sales 2023 0.63 x
P/E ratio 2022
4.98 x
P/E ratio 2023
8.36 x
Employees 364
Yield 2022
6.98%
Yield 2023
-
Free-Float 41.17%
More Fundamentals * Assessed data
Dynamic Chart
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Nigeria is working on COVID-19 vaccine, president says RE
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
Current month+9.09%
1 month+9.09%
3 months-19.03%
6 months+22.45%
Current year+14.29%
More quotes
1 week
6.00
Extreme 6
6.00
1 month
6.00
Extreme 6
6.64
Current year
4.75
Extreme 4.75
8.50
1 year
3.90
Extreme 3.9
8.50
3 years
3.35
Extreme 3.35
8.50
5 years
1.79
Extreme 1.79
8.50
10 years
0.80
Extreme 0.8
8.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 13-12-31
Compliance Officer - -
Members of the board TitleAgeSince
- -
Director/Board Member - 13-03-13
Director of Finance/CFO - 13-12-31
More insiders
Date Price Change Volume
24-04-30 6 -.--% 184,673
24-04-29 6 -.--% 349,502
24-04-26 6 -.--% 120,650
24-04-25 6 -.--% 39,027
24-04-24 6 -.--% 19,077

End-of-day quote Nigerian S.E., April 29, 2024

More quotes
May and Baker Nigeria Plc is a diversified group organized around 2 areas of activity: - manufacturing of pharmaceutical products and vaccines (99.8% of net sales); - manufacturing and distribution of mineral water (0.2%): Lily brand. All net sales are earned in Nigeria.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6 NGN
Average target price
6.92 NGN
Spread / Average Target
+15.33%
Consensus
  1. Stock Market
  2. Equities
  3. MAYBAKER Stock